Superorganism Closes $25.9M Debut Fund to Pioneer Biodiversity-Focused Venture Capital

New updates have been reported about Superorganism.

Superorganism, a venture firm launched in 2023 to put biodiversity at the center of venture investing, has closed its first fund with $25.9 million in commitments, hitting its $25 million target despite a more volatile political and policy environment around climate issues. The fund is backed by institutional investors including Cisco Foundation, AMB Holdings, and Builders Vision, as well as notable individuals such as Jeff Jordan of Andreessen Horowitz, signaling growing institutional acceptance of biodiversity as a distinct, investable thesis. Positioning itself as a “conservationist on the cap table,” Superorganism targets three categories: technologies that slow or reverse species extinction, companies at the intersection of climate and biodiversity, and tools that increase the effectiveness and productivity of conservation professionals. The firm typically invests $250,000 to $500,000 in pre-seed and seed rounds, expects to build a portfolio of roughly 35 companies from this first fund (20 are already in place), and has committed to donate 10% of its profits to future conservation efforts, directly linking its financial upside to environmental outcomes.

Managing directors Kevin Webb and Tom Quigley built the firm around the idea that biodiversity loss deserves the same focused capital and innovation that climate tech has attracted, but with a distinct impact lens and different regulatory and commercial drivers. The portfolio is intentionally diversified across industries, technologies, and policy regimes to reduce exposure to sector-specific or political headwinds and to demonstrate what top-tier biodiversity businesses can look like at scale. One example is Spoor, whose computer-vision platform tracks bird movements to help wind developers comply with wildlife regulations and avoid costly delays or shutdowns, illustrating Superorganism’s thesis that biodiversity-focused tools can create both regulatory risk mitigation and economic value. Another portfolio company, Inversa, which converts invasive species into leather products and recently drew public praise from Florida governor Ron DeSantis for its role in addressing python overpopulation, shows how biodiversity solutions can gain bipartisan traction and local governmental support. Quigley notes that many limited partners initially conflated biodiversity with generic climate funds, but differentiation became clear once they examined Superorganism’s portfolio mix and the distinct follow-on investors and customers these companies attract; with this first fund closed, the firm now aims to use its role as an early specialist to draw more capital into biodiversity and help other investors place their initial bets in the space.